Oragenics (0A64) Stock Statistics & Valuation Metrics
Total Valuation
Oragenics has a market cap or net worth of $1.69M. The enterprise value is $4.95M.
- Market Cap
- $1.69M
- Enterprise Value
- $4.95M
Share Statistics
Oragenics has 4,511,957 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,511,957
- Owned by Insiders
- 3.37%
- Owned by Institutions
- 1.05%
Financial Efficiency
Oragenics’s return on equity (ROE) is -1.19 and return on invested capital (ROIC) is -108.52%.
- Return on Equity (ROE)
- -1.19
- Return on Assets (ROA)
- -0.98
- Return on Invested Capital (ROIC)
- -108.52%
- Return on Capital Employed (ROCE)
- -1.13
- Revenue Per Employee
- 0
- Profits Per Employee
- -3.28M
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Oragenics is -0.10. Oragenics’s PEG ratio is -0.00.
- PE Ratio
- -0.10
- PS Ratio
- 0.00
- PB Ratio
- 0.45
- Price to FCF
- -0.16
- Price to Operating Cash Flow
- -0.16
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Oragenics had revenue of 0 and earned -9.84M in profits. Earnings per share was -4.56.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -9.36M
- Pretax Income
- -9.98M
- Net Income
- -9.84M
- EBITDA
- 762.24M
- Earnings Per Share (EPS)
- -4.56
Cash Flow
In the last 12 months, operating cash flow was -10.21M and capital expenditures 1, giving a free cash flow of -10.21M billion.
- Operating Cash Flow
- -10.21M
- Free Cash Flow
- -10.21M
- Free Cash Flow per Share
- -2.30
Dividends & Yields
Oragenics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -611.10%
- Earnings Yield
- -615.05%
Stock Price Statistics
- Beta
- 0.98
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 5.13
- 200-Day Moving Average
- 5.13
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Oragenics upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 12, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Oragenics as a current ratio of 5.64, with Debt / Equity ratio of 2.75%
- Current Ratio
- 5.64
- Quick Ratio
- 5.64
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- -0.01
- Interest Coverage Ratio
- -11.91
Taxes
In the past 12 months, Oragenics has paid -136.91K in taxes.
- Income Tax
- -136.91K
- Effective Tax Rate
- 0.01
Enterprise Valuation
Oragenics EV to EBITDA ratio is 0.31, with an EV/FCF ratio of 0.21.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.31
- EV to Free Cash Flow
- 0.21
- EV to Operating Cash Flow
- 0.21
Balance Sheet
Oragenics has $3.86M in cash and marketable securities with $0.00 in debt, giving a net cash position of $3.86M billion.
- Cash & Marketable Securities
- $3.86M
- Total Debt
- $0.00
- Net Cash
- $3.86M
- Net Cash Per Share
- $0.86
- Tangible Book Value Per Share
- $0.83
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
